Saturday, July 11, 2026

Drug profile · INN

jaktinib hydrochloride tablets

jaktinib hydrochloride tablets is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — jaktinib hydrochloride tablets
Class
Route
Patents
0
Programs
2
Data quality
0.70

Quick answer

jaktinib hydrochloride tablets is an FDA-listed pharmaceutical active ingredient.

Key facts

INN jaktinib hydrochloride tablets

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. JAK Inhibitor Approved · First People's Hospital · Dermatomyositis, Adult Type
  2. JAK Inhibitor Unknown · Chinese Academy of · Antisynthetase Syndrome

Frequently asked questions

What is jaktinib hydrochloride tablets?

jaktinib hydrochloride tablets is an FDA-listed pharmaceutical active ingredient.